Cognitive/neurodegenerative disorders: Phase I trials

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects


Phase I

Parkinsons, dementia

United States


ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease

DBSf (Deep Brain Stimulation of the Fornix)

Phase I

Alzheimer's (mild to moderate)

USA & Canada

Ongoing, not recruiting

Click here for further information

Neuroinflammation and Cognitive Decline in Alzheimer Disease (NICAD)

ADAS-Cog evaluation

Phase I


Study is not yet open for participant recruitment

Click here for further information